SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank50
3Y CAGR-5.5%
5Y CAGR+15.4%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-5.5%/yr
Annual compound
5Y CAGR
+15.4%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $13.84M | +49.3% |
| 2024 | $9.28M | -61.0% |
| 2023 | $23.80M | +45.3% |
| 2022 | $16.38M | -4.1% |
| 2021 | $17.09M | +152.3% |
| 2020 | $6.77M | +65.3% |
| 2019 | $4.10M | - |